Making an Impact for Stomach Cancer Patients With Lawmakers in Washington, DC
I was diagnosed with stage IV advanced, incurable stomach (gastric) cancer in April 2008 when I was only 40 years old
Pollack Discusses Ongoing Research for Patients With Refractory mCRC and Other Hard-to-Treat GI Malignancies
Pollack Offers Perspective on 2023 ASCO GI Cancers Symposium
Nivolumab/Cabozantinib Shows Continued Benefit In Frontline Treatment of RCC
Goodman Highlights Potential Benefit of SBRT in Locally Advanced Pancreatic Cancer
